FDA says it will receive until 10/30 joint applications from drug manufacturers and qualified research institutions to be one of 8-10 applicants chosen to participate in the new Expedited IND Pilot program.
Medical Devices
FDA Launches Medical Device Regulatory Reliance Portal
CDRH launches a new regulatory reliance portal to help foreign regulators use FDA medical device reviews and regulatory decisions to streamline their own oversight and potentially accelerate devices to market.
